Literature DB >> 22047493

Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes.

Jin Zhou1, Upendra A Argikar, Rory P Remmel.   

Abstract

AIM: To investigate the effects of two nonsynonymous SNPs, UGT1A4*2 (rs#: 6755571, 70C>A, P24T) and UGT1A4*3 (rs#: 2011425, 142T>G, L48V), on the function of UGT1A4 against dihydrotestosterone (DHT), transandrosterone (t-AND), lamotrigine (LTG) and tamoxifen (TAM). MATERIALS &
METHODS: Detailed kinetic experiments were conducted with recombinant UGT1A4(wild-type), UGT1A4(P24T) and UGT1A4(L48V), which were overexpressed in HEK293 cell lines. The kinetic profiles and kinetic parameters (K(m), V(max) and CL(int)) obtained with either UGT1A4(P24T) or UGT1A4(L48V) were compared with those obtained with the wild-type enzyme. The interaction of TAM on UG1A4-catalyzed DHT glucuronidation was also investigated with the three UGT1A4 polymorphic enzymes.
RESULTS: UGT1A4(L48V) had higher enzyme efficiency (CL(int)) compared with wild-type UGT1A4 on DHT glucuronidation; UGT1A4(P24T) and UGT1A4(L48V) had lower CL(int) than wild-type UGT1A4 for t-AND and LTG glucuronidation. The TAM CL(int) with UGT1A4(P24T) and UGT1A4(L48V) glucuronidation and the UGT1A4(P24T)-catalyzed DHT glucuronidation were, on the other hand, similar to those of the wild-type enzyme. With all three enzymes, TAM activated UGT1A4-catalyzed DHT glucuronidation in a concentration-dependent fashion.
CONCLUSION: Decreased CL(int) of UGT1A4(P24T) and UGT1A4(L48V) on LTG glucuronidation may lead to interindividual variations in LTG metabolism in vivo. However, it is less likely that these polymorphisms would have impact on DHT and t-AND metabolism in vivo because these compounds are glucuronidated by multiple enzymes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22047493     DOI: 10.2217/pgs.11.105

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  15 in total

Review 1.  Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.

Authors:  Upendra A Argikar; Philip M Potter; J Matthew Hutzler; Punit H Marathe
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

2.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

3.  Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic data.

Authors:  Jiachang Gong; Lisa Iacono; Ramaswamy A Iyer; William G Humphreys; Ming Zheng
Journal:  Br J Clin Pharmacol       Date:  2018-04-10       Impact factor: 4.335

4.  Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.

Authors:  Marisol López; Pedro Dorado; Alberto Ortega; Eva Peñas-Lledó; Nancy Monroy; Irma Silva-Zolezzi; Jesús Cobaleda; Alicia Gallego-Aguilera; María Elisa Alonso; Adrián Llerena
Journal:  Mol Biol Rep       Date:  2013-01-01       Impact factor: 2.316

5.  Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine.

Authors:  Arne Reimers; Wenche Sjursen; Grethe Helde; Eylert Brodtkorb
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-10       Impact factor: 2.441

6.  Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.

Authors:  Vineetha Koroth Edavana; Ishwori B Dhakal; Suzanne Williams; Rosalind Penney; Gunnar Boysen; Aiwei Yao-Borengasser; Susan Kadlubar
Journal:  Drug Metab Dispos       Date:  2013-01-31       Impact factor: 3.922

7.  Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.

Authors:  Daniela Milosheska; Bogdan Lorber; Tomaž Vovk; Matej Kastelic; Vita Dolžan; Iztok Grabnar
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

8.  Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.

Authors:  Limin Liu; Limei Zhao; Qiuning Wang; Feng Qiu; Xiujun Wu; Yanan Ma
Journal:  Eur J Clin Pharmacol       Date:  2015-08-26       Impact factor: 2.953

9.  A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives.

Authors:  Aleksandra K Greer; Centdrika R Dates; Athena Starlard-Davenport; Vineetha K Edavana; Stacie M Bratton; Ishwori B Dhakal; Moshe Finel; Susan A Kadlubar; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2014-06-10       Impact factor: 3.922

10.  Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.

Authors:  Shansen Xu; Limin Liu; Yanan Chen; Mei Liu; Tong Lu; Huanxin Wang; Shihao Liu; Mingming Zhao; Limei Zhao
Journal:  Eur J Clin Pharmacol       Date:  2018-01-16       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.